Xenon Pharmaceuticals Inc.
XENE
Ранг среди акций
#4417
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company... Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of other neurological conditions. The portfolio also includes NBI-921352, a selective inhibitor of the Nav1.6 sodium channel, which is undergoing Phase II clinical evaluation for SCN8A developmental and epileptic encephalopathy, alongside investigations for adult focal epilepsy and other potential indications. Furthermore, XEN007, a central nervous system-acting calcium channel modulator, is also in Phase II development. Beyond its internal development, Xenon Pharmaceuticals has established strategic collaborations. This includes a licensing and development agreement with Neurocrine Biosciences, Inc. focused on epilepsy treatments, and a partnership with Flexion Therapeutics, Inc. to advance PCRX301 (also known as XEN402), a Nav1.7 inhibitor, for post-operative pain management. Established in 1996, the company continues its mission to address significant unmet medical needs in neurology.
Цена акции
$36.43
Рыночная капитализация
$3.53B
Изменение (1 день)
3.85%
Изменение (1 год)
-16.13%
Страна
CA
Торговля Xenon Pharmaceuticals Inc. (XENE)
Категория
Healthcare
Количество находящихся в обращении акций Xenon Pharmaceuticals Inc. (XENE)
Количество акций в обращении на June 2026: 99.61M
Согласно последним финансовым отчетам и цене акций Xenon Pharmaceuticals Inc., текущее количество акций в обращении составляет 99.61M. На конец December 2023 у компании было 66.89M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Xenon Pharmaceuticals Inc. (XENE) с 2011 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 99.61M | 27.88% |
| 2024 | 77.89M | 16.45% |
| 2023 | 66.89M | 10.48% |
| 2022 | 60.54M | 38.77% |
| 2021 | 43.63M | 26.30% |
| 2020 | 34.54M | 33.17% |
| 2019 | 25.94M | 33.53% |
| 2018 | 19.43M | 8.01% |
| 2017 | 17.99M | 16.08% |
| 2016 | 15.49M | 8.48% |
| 2015 | 14.28M | 2.89% |
| 2014 | 13.88M | 52.78% |
| 2013 | 9.09M | 582.58% |
| 2012 | 1.33M | 0.14% |
| 2011 | 1.33M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 253.90M | 154.89% |
US
|
|
| 396.00M | 297.55% |
US
|
|
| 478.91M | 380.79% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -37.57% |
NL
|
